Survival Analysis Part IV: Further concepts and methods in survival analysis
暂无分享,去创建一个
D G Altman | S. Love | D. Altman | M. Bradburn | T. Clark | S. Love | T G Clark | M J Bradburn | S B Love | M. Bradburn
[1] J M Robins,et al. An analytic method for randomized trials with informative censoring: Part 1 , 1995, Lifetime data analysis.
[2] S. Love,et al. Survival Analysis Part II: Multivariate data analysis – an introduction to concepts and methods , 2003, British Journal of Cancer.
[3] J G Ibrahim,et al. Estimating equations with incomplete categorical covariates in the Cox model. , 1998, Biometrics.
[4] D G Altman,et al. Practical problems in fitting a proportional hazards model to data with updated measurements of the covariates. , 1994, Statistics in medicine.
[5] D G Altman,et al. What do we mean by validating a prognostic model? , 2000, Statistics in medicine.
[6] P. V. Rao,et al. Applied Survival Analysis: Regression Modeling of Time to Event Data , 2000 .
[7] P Royston,et al. The use of fractional polynomials to model continuous risk variables in epidemiology. , 1999, International journal of epidemiology.
[8] M Schumacher,et al. Effects of covariate omission and categorization when analysing randomized trials with the Cox model. , 1997, Statistics in medicine.
[9] N. Keiding,et al. The role of frailty models and accelerated failure time models in describing heterogeneity due to omitted covariates. , 1997, Statistics in medicine.
[10] D G Altman,et al. A prognostic model for ovarian cancer , 2001, British Journal of Cancer.
[11] James M. Robins,et al. An analytic method for randomized trials with informative censoring: Part II , 1995, Lifetime data analysis.
[12] Douglas G Altman,et al. Quantification of the completeness of follow-up , 2002, The Lancet.
[13] Douglas G. Altman,et al. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials , 2001, The Lancet.
[14] Jesse A. Berlin,et al. Assessing the Generalizability of Prognostic Information , 1999 .
[15] D. Moher,et al. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials , 2001, The Lancet.
[16] D. Altman. Suboptimal analysis using 'optimal' cutpoints. , 1998, British Journal of Cancer.
[17] W. Vach,et al. On the misuses of artificial neural networks for prognostic and diagnostic classification in oncology. , 2000, Statistics in medicine.
[18] Berthold Lausen,et al. Classification and regression trees (CART) used for the exploration of prognostic factors measured on different scales , 1994 .
[19] D. Sargent,et al. Comparison of artificial neural networks with other statistical approaches , 2001, Cancer.
[20] Douglas G Altman,et al. Developing a prognostic model in the presence of missing data: an ovarian cancer case study. , 2003, Journal of clinical epidemiology.
[21] M Schumacher,et al. Comparison of the Cox model and the regression tree procedure in analysing a randomized clinical trial. , 1993, Statistics in medicine.
[22] Orton,et al. Multiple Imputation in Practice , 2001 .
[23] H. Boshuizen,et al. Multiple imputation of missing blood pressure covariates in survival analysis. , 1999, Statistics in medicine.
[24] D Scharfstein,et al. Inference in Randomized Studies with Informative Censoring and Discrete Time‐to‐Event Endpoints , 2001, Biometrics.
[25] S. Love,et al. Survival Analysis Part III: Multivariate data analysis – choosing a model and assessing its adequacy and fit , 2003, British Journal of Cancer.
[26] E Biganzoli,et al. Feed forward neural networks for the analysis of censored survival data: a partial logistic regression approach. , 1998, Statistics in medicine.
[27] John O'Quigley,et al. Proportional hazards models with frailties and random effects , 2002, Statistics in medicine.
[28] J. Wyatt,et al. Commentary: Prognostic models: clinically useful or quickly forgotten? , 1995 .
[29] Sunil J Rao,et al. Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis , 2003 .
[30] R. Kay. Treatment effects in competing-risks analysis of prostate cancer data. , 1986, Biometrics.
[31] S. Piantadosi,et al. A quantitative study of the bias in estimating the treatment effect caused by omitting a balanced covariate in survival models. , 1988, Statistics in medicine.
[32] W. Sauerbrei,et al. Dangers of using "optimal" cutpoints in the evaluation of prognostic factors. , 1994, Journal of the National Cancer Institute.
[33] D. G. Altman,et al. Statistical aspects of prognostic factor studies in oncology. , 1994, British Journal of Cancer.
[34] T. Yamaguchi,et al. Proportional hazards models with random effects to examine centre effects in multicentre cancer clinical trials , 2002, Statistical methods in medical research.
[35] Patrick van der Smagt,et al. Introduction to neural networks , 1995, The Lancet.
[36] D Machin,et al. Competing risks analysis of patients with osteosarcoma: a comparison of four different approaches , 2001, Statistics in medicine.
[37] T G Clark,et al. Survival Analysis Part I: Basic concepts and first analyses , 2003, British Journal of Cancer.
[38] Teri Oldaker,et al. Making the most of your prognostic factors: Presenting a more accurate survival model for breast cancer patients , 2005, Breast Cancer Research and Treatment.